Special Issue "Pharmacy Reviews in 2022"

A special issue of Pharmacy (ISSN 2226-4787).

Deadline for manuscript submissions: 31 December 2022 | Viewed by 1748

Special Issue Editors

Prof. Dr. Jon Schommer
E-Mail Website
Guest Editor
College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA
Interests: Information processing and decision making related to the provision, use, and evaluation of drug products and pharmacist services
Special Issues, Collections and Topics in MDPI journals
Prof. Dr. Jack E. Fincham
E-Mail Website
Guest Editor
Osher Life Long Learning Institute, University of Arizona, Tuscon, AZ, USA
Interests: health policy; health outcomes; pharmacoepidemiology; pharmacoeconomics; global health

Special Issue Information

Dear Colleagues,

We are pleased to announce this Special Issue, entitled “Pharmacy Reviews in 2022”. This Special Issue will be a collection of high-quality reviews from Editorial Board members, Guest Editors, and leading researchers invited by the Editorial Office as well as the Special Issue Editors. Submissions on all aspects of "Pharmacy Education and Practice" are welcome.

Prof. Dr. Jon Schommer
Prof. Dr. Jack Fincham
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmacy is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:


The Potential of Methocinnamox as a Future Treatment for Opioid Use Disorder: A Narrative Review
Pharmacy 2022, 10(3), 48; https://doi.org/10.3390/pharmacy10030048 - 19 Apr 2022
Viewed by 1333
The opioid epidemic is an ongoing public health crisis, and the United States health system is overwhelmed with increasing numbers of opioid-related overdoses. Methocinnamox (MCAM) is a novel mu opioid receptor antagonist with an extended duration of action. MCAM has potential to reduce [...] Read more.
The opioid epidemic is an ongoing public health crisis, and the United States health system is overwhelmed with increasing numbers of opioid-related overdoses. Methocinnamox (MCAM) is a novel mu opioid receptor antagonist with an extended duration of action. MCAM has potential to reduce the burden of the opioid epidemic by being used as an overdose rescue treatment and a long-term treatment for opioid use disorder (OUD). The currently available treatments for OUD include naloxone, naltrexone, and methadone. These treatments have certain limitations, which include short duration of action, patient non-compliance, and diversion. A narrative review was conducted using PubMed and Google Scholar databases covering the history of the opioid epidemic, pain receptors, current OUD treatments and the novel drug MCAM. MCAM could potentially be used as both a rescue and long-term treatment for opioid misuse. This is due to its pseudo-irreversible antagonism of the mu opioid receptor, abnormally long duration of action of nearly two weeks, and the possibility of using kappa or delta opioid receptor agonists for pain management during OUD treatment. MCAM’s novel pharmacokinetic and pharmacodynamic properties open a new avenue for treating opioid misuse. Full article
(This article belongs to the Special Issue Pharmacy Reviews in 2022)
Show Figures

Graphical abstract

Planned Papers

The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.

1. Title: Pharmacy Workplace Wellbeing and Resilience
Authors: Jon Schommer; Caroline Gaither
Affiliation: College of Pharmacy, University of Minnesota, Minneapolis, MN, USA
Abstract: Pharmacists and pharmacy personnel’s workplace issues and their relationship to personal well-being continue to be a critical, complex issue across all practice settings, and have been further exacerbated under the COVID-19 pandemic. Also, pharmacists and pharmacy personnel’s workload has been linked to patient safety concerns regarding medication errors. What is needed now is a critical examination of workplace factors to determine how they affect pharmacy personnel well-being and patient safety.

2. Title: pharmacy services from a public health perspective
Authors: Laetitia Hattingh; et al.
Affiliation: School of Pharmacy and Pharmacology, Griffith University, Gold Coast campus, 4215, Queensland, Australia

3. Title: Advances in Pharmacy Practice, Policy, Education and Training: A look towards into the next 10-20 years
Authors: Jeffrey Atkinson; et al.
Affiliation: Pharmacolor Consultants Nancy, 12 rue de Versigny, Villers 54600, France

4. Title: Gabapentinoid Prescribing: Impacts on Pharmacy Regulation and Policies
Authors: Helen Gallagher; Colette Morris
Affiliation: School of Medicine & Medical Science, Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland

5. Title: Using precision medicine concepts to optimize empirical antimicrobial therapy of acute pyelonephritis
Authors: Majdi N. Al-Hasan; et al.
Affiliation: School of Medicine, University of South Carolina, Columbia, SC 29208, USA

6. Title: Professionalism Curriculum in Pharmacy Education
Authors: Melany P. Puglisi; Elmer Gentry
Affiliation: Department of Pharmaceutical Sciences, Chicago State University, 9501 S. King Drive, Chicago, IL 60623, USA
Abstract: In the last ten years, pharmacy employers and preceptors (initial/advanced pharmacy practice experiences) have identified the need to develop a formal professionalism curriculum to prepare practice ready graduates. Institutions have employed new and different strategies to include professionalism in the didactic curriculum and co-curricular activities to address this change. A review and assessment of teaching methods in this area is timely and valuable to expanding the professionalism curriculum in pharmacy education.

7. Title: Are Pharmacy Practice and Education Inclusive?
Authors: Gisselle Gallego; et al.
Affiliation: School of Medicine, Sydney, The University of Notre Dame Australia, Sydney, AustraliaDepartment of Pharmacology and Clinical Neuroscience, Umeå University, Umeå, Sweden
Abstract: Despite the benefits of including people with disabilities in the health workforce, the number of pharmacy students or pharmacists with disability continue to be low. This review will describe the potential barriers and facilitators for inclusive pharmacy education and practice.

Back to TopTop